You're right that the medications that I'm referring to are propofol and Midazolam. There's also fentanyl. What's happening is that people who are presenting with COVID-19 and have significant respiratory distress, when we've had to sedate them and put them on ventilators, many of them have had to be on ventilators for much longer periods of time than we usually have people on ventilators, so that has increased not only the length of time we use the medications but also the volume of patients that we now have in our ICUs.
Ventolin is also in short supply. That's more of a community issue right now. In hospitals, we're okay with Ventolin.
We're basically working through our usual partners. The Ministry of Health and its sources is one of the partners, but we have significant relationships with our supply chain, with our drug companies, because of the large amounts of purchasing that we do, as many hospitals do throughout Ontario. Right now, just as with PPE, since the issue is not localized to Canada and China, or to Ontario and China as in the case of SARS, but is a worldwide issue, the suppliers are probably not able to create it as fast as they need to.
Once again, this goes back to what we can do to prepare and have these things on hand. I know that unlike PPE, drugs will expire, so that is something that we'll have to go back and look in a more innovative way at how we can cycle these through our warehouses so that if an event like this occurs again, or if and when an event like this occurs again, we can be much better prepared.